Apixaban for Treatment of Atrial Fibrillation and Venous Thromboembolism After Lung Transplantation [0.03%]
阿哌沙班用于治疗肺移植后房颤和静脉血栓栓塞症
Anne Nikodem,Ashwini Arjuna,Chengcheng Hu et al.
Anne Nikodem et al.
Introduction: Guidelines recommend the use of direct oral anticoagulation therapy over warfarin for the treatment of venous thromboembolism and atrial fibrillation. However, there is uncertainty and a lack of data support...
Kathryn Norville,Jenise Stephen,Carolyn Mead-Harvey et al.
Kathryn Norville et al.
Introduction: Eculizumab is a monoclonal antibody that binds to complement protein C5, inhibiting complement-mediated thrombotic microangiopathy. It is approved for several indications including atypical hemolytic uremic syndrome. Additiona...
A Nominal Group Technique Study of Patients Who Identify as Black or African American and Access to Renal Transplantation [0.03%]
一项名义小组技术研究：自认为是黑人或非裔美国人患者的肾脏移植准入问题
Camilla W Nonterah,Shawn O Utsey,Gaurav Gupta et al.
Camilla W Nonterah et al.
Introduction: Completion of the renal transplant evaluation has been associated with several barriers for patients who identify as Black or African American. This study sought to prioritize barriers to and motivators of completing the renal...
Goal-Directed Haemodynamic Therapy Improves Patient Outcomes in Kidney Transplantation [0.03%]
目标导向的血流动力学治疗可改善肾移植患者的预后
Jez Fabes,Ammar Al Midani,Aman S Sarna et al.
Jez Fabes et al.
Introduction: Kidney transplant graft function depends on optimised haemodynamics. However, high fluid volumes risk hypervolaemic complications. The Edwards Lifesciences ClearSight™ device permits fluid titration through markers of preload...
Rebecca P Winsett
Rebecca P Winsett
A Systematic Review and Meta-Analysis of Posttransplant Anemia With Overall Mortality and Cardiovascular Outcomes Among Kidney Transplant Recipients [0.03%]
系统综述和荟萃分析：肾移植受者术后贫血与总体死亡率及心血管结局的关系
Poemlarp Mekraksakit,Natnicha Leelaviwat,Juthipong Benjanuwattra et al.
Poemlarp Mekraksakit et al.
Introduction: Posttransplant anemia is a common finding after kidney transplantation. A previous meta-analysis reported an association between anemia and graft loss. However, data on cardiovascular outcomes have not yet been reported. Objec...
Tacrolimus Formulation, Exposure Variability, and Outcomes in Kidney Transplant Recipients [0.03%]
他克莫司的制剂，暴露变异及对肾移植受者结局的影响
Elaine F Lai,Huong Thao Nguyen,Olusegun Famure et al.
Elaine F Lai et al.
Introduction: Few studies have compared within-patient variability measures of tacrolimus trough levels by formulation and assessed within-patient variability on outcomes of kidney transplant recipients. ...
A Home Education Service to Increase Knowledge of Treatment Options and Improve Attitudes to Living Donor Kidney Transplantation [0.03%]
一项在家教育服务以增加对治疗选择的了解并改善对活体捐赠肾脏移植的态度
Orla Hobson,Jen Lumsdaine,Ahmed Sherif et al.
Orla Hobson et al.
Introduction: Lack of knowledge about living donor kidney transplant and difficulties in approaching potential donors constitute barriers for many patients and may contribute to inequality of access. Project Aims: Renal Education and Choice...
Development and Validation of a Model to Predict Malignancy Within the First Year After Adult Heart Transplantation [0.03%]
用于预测成人心脏移植后第一年内恶性肿瘤发生发展的模型的建立和验证
William L Baker,Timothy E Moore,Eric Baron et al.
William L Baker et al.
Purpose: Malignancy after heart transplantation is associated with poor outcomes. At present, no prediction model exists for any malignancy within the first year after transplant. Methods: We studied adults who underwent heart transplantati...
External Validation of the United Kingdom Transplant Benefit Score in Australia and New Zealand [0.03%]
英国移植效益评分在澳大利亚和新西兰的外部验证研究
Eunice G Lee,Marcos V Perini,Enes Makalic et al.
Eunice G Lee et al.
Introduction: In Australia and New Zealand, liver allocation is needs based (based on model for end-stage liver disease score). An alternative allocation system is a transplant benefit-based model. Transplant benefit is quantified by comple...